Evidence map›Paper›PMID 38157868›Full record

ArticleArchives of pathology & laboratory medicine2024

In Support of Magnani and Taylor.

David J Dabbs, Luis A Chiriboga, Bharat Jasani, Mary A Kinloch, Keith D Miller, Søren Nielsen, Matthias J Szabolcs, Emina Torlakovic, Steve Bogen, Suzanne Parry and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of pathology & laboratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David J DabbsDepartment of Pathology, PreludeDx, Laguna Hills, California.
Luis A ChiribogaDepartment of Pathology & Center for Biospecimen Research and Development, NYU Grossman School of Medicine, New York, New York.
Bharat JasaniInstitute of Cancer & Genetics and Department of Cancer Pathology, Cardiff University, Cardiff, Wales, United Kingdom.
Mary A KinlochDepartment of Pathology and Laboratory Medicine, University of Saskatchewan & Saskatoon Health Authority, Saskatoon, Saskatchewan, Canada.
Keith D MillerDepartment of Pathology, Institute of Biomedical Science, The Cancer Institute, University College, London Research, London, United Kingdom.
Søren NielsenNordiQC, Aalborg, Denmark.
Matthias J SzabolcsDepartment of Pathology, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.
Emina TorlakovicDepartment of Pathology, University of Saskatchewan & Saskatoon Health Authority, Royal University Hospital, Saskatoon, Saskatchewan, Canada.
Steve BogenDepartment of Pathology, Boston Cell Standards & Tufts Medical Center, Boston, Massachusetts.
Suzanne ParryDepartment of Immunocytochemistry and In-Situ Hybridisation, UK NEQAS-ICC/ISH, London, United Kingdom.
Nils A 't HartDepartment of Pathology, Isala, Zwolle, The Netherlands.

Funding

National Immunohistochemistry Standardization Program - Establishment & LaunchR44CA268484 · NCI · BOSTON CELL STANDARDS INC · PI BOGEN, STEVEN A · 2021 to 2022
$2.0M
NCI NIH HHS R44 CA268484
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38157868
PMCPMC11749498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.